Ex Parte JARVEST et al - Page 6




              Appeal No. 2000-0599                                                                                        
              Application No. 08/357,363                                                                                  
              claims when the claims are read in light of the specification.  See Orthokinetics, Inc. v.                  
              Safety Travel Chairs, Inc., 806 F.2d 1565, 1576, 1 USPQ2d 1081, 1088 (Fed. Cir.                             
              1986).                                                                                                      
                     Turning to the specification (page 5), we find the following passage to be                           
              instructive:                                                                                                
                     [A] preferred compound of the present invention is the compound of                                   
                     formula (A) [ 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine] or a salt or                            
                     acyl derivative thereof.                                                                             
                     In a further aspect of the invention there is provided a compound of                                 
                     formula (A) in a purity state of greater than 60% preferably greater than                            
                     80% more preferably greater than 90% and particularly preferably more                                
                     than 95% by weight of pure compound.                                                                 
                     In yet a further aspect of the invention, there is provided an isolated,                             
                     substantially completely pure compound of formula (A), or a                                          
                     pharmaceutically acceptable salt thereof.                                                            
                     Thus, the specification indicates that the invention encompasses the compound,                       
              9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine, or its salt, in various states of purity:                    
              e.g., Ain a purity state of greater than 60%,@ Agreater than 80%,@ Agreater than 90%,@                      
              Amore than 95% by weight of pure compound,@ and finally, Ayet a further@ level of purity -                  
              Asubstantially completely pure.@  Given this progression, we believe that one skilled in                    
              the art would understand claims 45 and 46 to require a level of purity more stringent                       
              than Amore than 95% by weight of pure compound.@  Like the ubiquitous term Aabout,@                         
              Athe term >substantially= is a descriptive term commonly used to >avoid a strict numerical                  
              boundary to the specified parameter.=@ Ecolab Inc. v. Envirochem Inc., 264 F.3d 1358,                       

                                                            6                                                             






Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007